INTERNATIONAL PATENT: UNIVERSITY OF WASHINGTON FILES APPLICATION FOR "DE NOVO DESIGNED BINDERS TARGETING THE TUMOR ASSOCIATED ANTIGENS HER2, CEACAM5, TROP2, BCMA, FAP AND ROR1"

GENEVA, Jan. 6 -- UNIVERSITY OF WASHINGTON (1100 Ne Campus Parkway, Suite 200Seattle, WA 98195) filed a patent application (PCT/US2025/034748) for "DE NOVO DESIGNED BINDERS TARGETING THE TUMOR ASSOCIATED ANTIGENS HER2, CEACAM5, TROP2, BCMA, FAP, AND ROR1" on Jun 23, 2025. With publication no. WO/2026/006160, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAKER, David (C/o University Of Washington1100 Ne Campus Parkway, Suite 200Seattle, WA 98195), COVENTRY, Brian (C/o University Of Washington1100 Ne Campus Parkway, Suite...